Zobrazeno 1 - 10
of 11
pro vyhledávání: '"BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Radioterapija i onkologija"'
Autor:
Golčić, Marin, Simetić, Luka, Herceg, Davorin, Blažičević, Krešimir, Kenđel Jovanović, Gordana, Dražić, Ivan, Belančić, Andrej, Skočibušić, Nataša, Palčevski, Dora, Rubinić, Igor, Vlahović-Palčevski, Vera, Majnarić, Tea, Dobrila-Dintinjana, Renata, Pleština, Stjepko
Publikováno v:
Cancers
Volume 15
Issue 11
Volume 15
Issue 11
Immunotherapy has improved the prognosis of metastatic melanoma patients, although most patients do not achieve a complete response. While specific gut microbiome and dietary habits might influence treatment success, there is a lack of concordance be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::043042e31c35011de101e153802a59d4
https://repository.medri.uniri.hr/islandora/object/medri:7733/datastream/FILE0
https://repository.medri.uniri.hr/islandora/object/medri:7733/datastream/FILE0
Autor:
Endres, Katharina
Objectives: The goal of this study was to evaluate whether the presence of EGFR (Epidermal Growth Factor Receptor) mutations in patients with NSCLC treated by radiochemotherapy, would have an impact on the disease prognosis and survival. Materials an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4112::7e385600cd7a6a670c9632e5e5be7498
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1533
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1533
Publikováno v:
Medical Hypotheses
Volume 161
Volume 161
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to its aggressiveness and resistance to anti-cancer medications. Recent data suggest that solid tumors such as PDAC are infected with microbial agents, which can induce aggre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5907be3682090b19da05acbad4dd96
https://www.bib.irb.hr/1189465
https://www.bib.irb.hr/1189465
Autor:
Rubić, Matea
Radioterapija predstavlja način liječenja zloćudnih tumora ionizirajućim zračenjem čiji je cilj maksimalno ozračiti tumorsku tvorbu uz što veću poštedu okolnog zdravog tkiva. Ovisno o vrsti i stadiju raka koriste se i različite tehnike rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4112::75b4c77c3421fb0aa479a016217dd5cf
https://repozitorij.svkst.unist.hr/islandora/object/ozs:1115
https://repozitorij.svkst.unist.hr/islandora/object/ozs:1115
Autor:
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić
Publikováno v:
Cancers
Volume 14
Issue 11
Cancers; Volume 14; Issue 11; Pages: 2688
Volume 14
Issue 11
Cancers; Volume 14; Issue 11; Pages: 2688
(1) Background: The aim of this study was to evaluate the efficacy and safety of SABR for LAPC using Calypso® Extracranial Tracking for intrafractional, fiducial-based motion management, to present this motion management technique, as there are yet
Autor:
Marin Golčić, Tatjana Ladenhauser, Tea Majnarić, Krešimir Blažičević, Davorin Herceg, Lukaa Simetić
Publikováno v:
Anti-Cancer Drugs
Volume 32
Volume 32
Objectives Soft-tissue sarcomas (STSs) are a heterogeneous group of rare malignancies. Treatment for advanced STS usually starts with anthracycline-based therapies, with no clear sequence for further treatment. A preferred option is trabectedin, espe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f85a81b62611c33739fe0d906d4815f0
https://www.bib.irb.hr/1158133
https://www.bib.irb.hr/1158133
Publikováno v:
Medicina Fluminensis : Medicina Fluminensis
Volume 53
Issue 3
Medicina Fluminensis
Volume 53
Issue 3
Medicina Fluminensis
Napredak u razumijevanju i poznavanju molekularnih puteva rasta i razvoja tumora bubrega doveo je do razvoja čitavog niza lijekova kojima je danas moguće liječiti oboljele od ove bolesti. Brojne kliničke studije dokazale su učinkovitost novih te
Autor:
Marija Petković, Marin Golčić
Publikováno v:
Medical Hypotheses
Volume 94
Volume 94
Metastatic renal cell carcinoma (mRCC) develops in approximately 33% of all renal cancer patients. First line treatment of mRCC includes drugs such as sunitinib, temsirolimus and pazopanib, with overall survival now reaching up to 43,6 months in pati
Publikováno v:
Collegium antropologicum
Volume 40
Issue 1
Volume 40
Issue 1
In human organism development is a very complex and highly regulated system that enables the functional balance of each organ in a whole body. Disorders and tumor micro-environment weaken host immune system that is not able to recognize the tumor as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cfe7f6c094285eac5854aed0483b6f74
https://www.bib.irb.hr/998052
https://www.bib.irb.hr/998052
Autor:
Bišof, Vesna, Juretić, Antonio, Stančić-Rokotov, Dinko, Rustemović, Nadan, Miletić, Damir, Boban, Marijo, Omrčen, Tomislav, Jakić Razumović, Jasminka, Pavlović, Ira, Fröbe, Ana, Čonkaš, Mislav, Rakušić, Zoran, Gugić, Damir
Publikováno v:
Liječnički Vjesnik
Volume 138
Volume 138
Rak jednjaka i ezofagogastričnog prijelaza obuhvaća histološki i biološki različite zloćudne tumore kod kojih se napredak u razumijevanju ovih bolesti još nije pretočio u znatnije poboljšanje preživljenja oboljelih. Dijagnoza se postavlja b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f95cd58036676db419b6ade6321c96df
https://urn.nsk.hr/urn:nbn:hr:184:259519
https://urn.nsk.hr/urn:nbn:hr:184:259519